Takeda, founded in 1781 in Osaka, Japan, operates in about 80 countries. The company established a commercial presence in India 13 years ago in Gurugram, currently employing around 200 people.

Beyond being a big deal for Takeda, which is the state’s largest ... the 16-story tower at 585 Kendall is one of the few major commercial projects underway in Greater Boston right now.

Takeda has three Phase 3 readouts this year for type 1 narcolepsy, polycythemia vera and psoriasis. “From the commercial standpoint, all of those teams are gearing up. We’re starting the ...

Q4 2024 Earnings Call Transcript February 11, 2025 Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.48 EPS, ...

In a long-term succession plan, the board of directors at Japan’s largest drugmaker Takeda has made the decision unanimously ...

Japanese drugmaker Takeda’s latest financial results were presented Thursday, though they took a back seat to the news that ...

“Takeda is a unique company ... decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or ...

Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process ...

PersonnelTakeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 202630-Jan-2025 / 09:31 CET/CESTDisclosure of an inside information acc. to Article 17 ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.